Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$839M |
| 2 |
Amazon
AMZN
|
+$810M |
| 3 |
Tesla
TSLA
|
+$644M |
| 4 |
TSMC
TSM
|
+$546M |
| 5 |
Johnson & Johnson
JNJ
|
+$389M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$891M |
| 2 |
Home Depot
HD
|
+$441M |
| 3 |
JPMorgan Chase
JPM
|
+$335M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$317M |
| 5 |
ASML
ASML
|
+$315M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.84% |
| 2 | Technology | 15.57% |
| 3 | Consumer Discretionary | 11.88% |
| 4 | Consumer Staples | 10.09% |
| 5 | Financials | 9.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2251
Cars.com
CARS
$663M
| $1.53M | ﹤0.01% |
110,900
+29,000
| +35% | +$393K |
|
2252
Certara
CERT
$1.22B
| $1.52M | ﹤0.01% |
94,900
+67,100
| +241% | +$973K |
|
2253
Esquire Financial Holdings
ESQ
$1.55B
| $1.52M | ﹤0.01% |
35,200
+9,300
| +36% | +$395K |
|
|
TRST
2254
Trustco Bank Corp NY
TRST
$977M
| $1.52M | ﹤0.01% |
40,476
-1,200
| -3% | -$43.8K |
|
2255
CarGurus
CARG
$3.33B
| $1.52M | ﹤0.01% |
+108,400
| New | +$1.49M |
|
|
LAND
2256
Gladstone Land Corp
LAND
$358M
| $1.52M | ﹤0.01% |
82,700
+10,400
| +14% | +$203K |
|
2257
Cabaletta Bio
CABA
$466M
| $1.51M | ﹤0.01% |
163,400
-524,061
| -76% | -$1.91M |
|
2258
First United
FUNC
$293M
| $1.51M | ﹤0.01% |
76,691
-1,804
| -2% | -$33.8K |
|
|
GDEN
2259
DELISTED
Golden Entertainment
GDEN
| $1.51M | ﹤0.01% |
40,296
-33,100
| -45% | -$1.36M |
|
2260
Infosys
INFY
$49B
| $1.51M | ﹤0.01% |
+83,700
| New | +$1.56M |
|
|
SCPH
2261
DELISTED
scPharmaceuticals
SCPH
| $1.51M | ﹤0.01% |
209,986
+29,700
| +16% | +$181K |
|
|
TESS
2262
DELISTED
Tessco Technologies Inc
TESS
| $1.5M | ﹤0.01% |
307,150
-24,654
| -7% | -$115K |
|
|
RPT
2263
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
| $1.5M | ﹤0.01% |
149,501
+21,700
| +17% | +$214K |
|
2264
CSP Inc
CSPI
$81.1M
| $1.5M | ﹤0.01% |
318,126
-22,228
| -7% | -$89.6K |
|
2265
Dorian LPG
LPG
$2.03B
| $1.5M | ﹤0.01% |
+79,100
| New | +$1.42M |
|
2266
Recursion Pharmaceuticals
RXRX
$1.69B
| $1.5M | ﹤0.01% |
193,900
+178,700
| +1,176% | +$1.75M |
|
2267
Alto Ingredients
ALTO
$324M
| $1.49M | ﹤0.01% |
518,700
+23,900
| +5% | +$85K |
|
|
CMBT
2268
CMB.TECH NV
CMBT
$5B
| $1.49M | ﹤0.01% |
+87,494
| New | +$1.58M |
|
2269
NetSol Technologies
NTWK
$48.3M
| $1.49M | ﹤0.01% |
516,018
-27,283
| -5% | -$84.3K |
|
|
DCPH
2270
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $1.49M | ﹤0.01% |
+90,700
| New | +$1.47M |
|
2271
Aldeyra Therapeutics
ALDX
$94.1M
| $1.49M | ﹤0.01% |
213,500
-164,800
| -44% | -$942K |
|
2272
Security National Financial
SNFCA
$242M
| $1.48M | ﹤0.01% |
246,747
-11,915
| -5% | -$63.7K |
|
|
TGH
2273
DELISTED
Textainer Group Holdings limited
TGH
| $1.48M | ﹤0.01% |
47,600
-98,100
| -67% | -$2.91M |
|
2274
Freedom Holding
FRHC
$9.34B
| $1.47M | ﹤0.01% |
+25,244
| New | +$1.45M |
|
2275
Global X MLP ETF
MLPA
$2.3B
| $1.47M | ﹤0.01% |
35,602
+11,140
| +46% | +$467K |
|
Similar funds
Jim Simons's Q4 2022 Portfolio in Review
As of Q4 2022, Jim Simons held 4,601 positions worth $73.1B, up 3.4% from $70.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons's Q4 2022 filing shows 626 new, 1,390 increased, 2,018 reduced and 522 closed positions. Its largest new stake was Johnson & Johnson: 2,254,125 shares worth $398M. The largest sale was Microsoft, an estimated $891M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jim Simons's largest Q4 2022 buy was Johnson & Johnson: 2,254,125 shares worth $398M.
- Jim Simons added most to Apple in Q4 2022, an estimated $839M increase.
- Jim Simons's biggest Q4 2022 reduction was Novo Nordisk, cutting an estimated $317M.
- Jim Simons fully exited Microsoft in Q4 2022, selling an estimated $891M.
- Jim Simons's ten largest holdings make up 11% of its $73.1B portfolio in Q4 2022.
- Jim Simons opened 626 new positions and closed 522 in Q4 2022.
- Jim Simons's portfolio value rose 3.4% quarter-over-quarter to $73.1B.
Based on Renaissance Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.